Incyte Corporation officer Steven Stein filed a Form 144 notice of proposed sale on November 6, 2026, covering 240,193 shares of Incyte common stock to be sold through Morgan Stanley Smith Barney LLC.
Key Highlights
- Proposed seller: Steven Stein, an officer of Incyte Corporation, filed the notice for his own account.
- Shares proposed for sale: 240,193 shares of Incyte common stock, with an aggregate market value of $28,345,175.93 as stated in the filing.
- Source of shares: The securities were acquired on November 6, 2026, through the exercise of stock options granted by the issuer, with payment made in cash on the same date.
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.
- Approximate date of sale: November 6, 2026, on the NASDAQ exchange.
- 10b5-1 plan: The filing indicates a Rule 10b5-1 plan adoption date of August 7, 2026.
- Prior sales: The filing reports nothing to report for securities sold during the past three months by the person filing the notice.
Incyte Officer Steven Stein Files Proposed Sale Notice for 240,193 Option Shares
According to the Form 144 filing submitted to the U.S. Securities and Exchange Commission, Steven Stein, identified as an officer of Incyte Corporation (NASDAQ:INCY), provided notice of a proposed sale of 240,193 shares of Incyte common stock. The filing lists an aggregate market value of $28,345,175.93 for the shares proposed to be sold. As of the filing, Incyte had 203,832,492 shares of common stock outstanding, according to the disclosure.
The filing states that the shares were acquired on November 6, 2026, through the exercise of stock options from the issuer, with the date of payment also listed as November 6, 2026, made in cash. The proposed sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services on the NASDAQ exchange, with an approximate sale date of November 6, 2026. Incyte Corporation is headquartered at 1801 Augustine Cut-Off, Wilmington, Delaware 19803, according to the issuer information section of the filing.
The filing notes that the sale is being conducted under a Rule 10b5-1 trading plan, with the plan adoption date listed as August 7, 2026. By signing the filing, Stein represented, as of the plan adoption date, that he did not know of any material adverse information regarding the current and prospective operations of Incyte that had not been publicly disclosed. The filing reports no securities sold by Stein during the past three months prior to this notice.
What Was Disclosed
Incyte officer Steven Stein filed a Form 144 notice proposing to sell 240,193 shares of Incyte common stock, acquired via stock option exercise, through Morgan Stanley Smith Barney LLC on NASDAQ on November 6, 2026, under a 10b5-1 plan adopted August 7, 2026.




Please wait processing your request...